Agilent Technologies (NYSE:A) Price Target Raised to $162.00 at TD Cowen

Agilent Technologies (NYSE:A) had its target price lifted by TD Cowen from $150.00 to $162.00 in a research report sent to investors on Tuesday,Benzinga reports. TD Cowen currently has a buy rating on the medical research company’s stock.

Other research analysts have also issued reports about the stock. Wells Fargo & Company lifted their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a report on Monday, September 15th. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. JPMorgan Chase & Co. lifted their price target on shares of Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Finally, Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $149.62.

Agilent Technologies Stock Down 0.1%

Shares of NYSE A opened at $138.12 on Tuesday. Agilent Technologies has a 1 year low of $96.43 and a 1 year high of $153.84. The firm’s 50 day moving average price is $125.97 and its 200 day moving average price is $117.31. The firm has a market cap of $39.16 billion, a P/E ratio of 32.42, a price-to-earnings-growth ratio of 4.51 and a beta of 1.26. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter last year, the business earned $1.32 EPS. Agilent Technologies’s revenue for the quarter was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, sell-side analysts anticipate that Agilent Technologies will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be paid a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 23.24%.

Institutional Investors Weigh In On Agilent Technologies

Large investors have recently made changes to their positions in the company. Capital A Wealth Management LLC grew its holdings in Agilent Technologies by 10,600.0% during the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after acquiring an additional 212 shares during the last quarter. Stone House Investment Management LLC bought a new stake in Agilent Technologies during the 1st quarter worth about $30,000. Opal Wealth Advisors LLC bought a new stake in Agilent Technologies during the 1st quarter worth about $31,000. Ransom Advisory Ltd bought a new stake in Agilent Technologies during the 1st quarter worth about $32,000. Finally, Central Pacific Bank Trust Division bought a new position in shares of Agilent Technologies in the 2nd quarter valued at about $33,000.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.